Literature DB >> 34725641

Corrigendum to "PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer".

Guang Li1, Guobing Liu2, Xuefeng Wang1.   

Abstract

[This corrects the article DOI: 10.1155/2021/5512340.].
Copyright © 2021 Guang Li et al.

Entities:  

Year:  2021        PMID： 34725641      PMCID： PMC8557080          DOI： 10.1155/2021/9762405

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


In the article titled “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer” [1], the authors wish to provide the following acknowledgement that was omitted in error: This work was financially supported by the Natural Science Foundation of Guangdong Province (2021A1515011050) and Science and Technology Projects in Guangzhou (202102080100). Additionally, the order of authors was listed incorrectly, and the correct order is as shown above.
  1 in total

1.  PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.

Authors:  Guang Li; Xuefeng Wang; Guobing Liu
Journal:  Biomed Res Int       Date:  2021-06-28       Impact factor: 3.411
  1 in total
  1 in total

1.  A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes.

Authors:  Luigi Scietti; Elisabetta Moroni; Daiana Mattoteia; Marco Fumagalli; Matteo De Marco; Lisa Negro; Antonella Chiapparino; Stefano A Serapian; Francesca De Giorgi; Silvia Faravelli; Giorgio Colombo; Federico Forneris
Journal:  Front Mol Biosci       Date:  2022-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.